Business Context and Reporting Period
Company: TherapeuticsMD, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 31, 2017
Reporting Period: This filing reports on events occurring on May 31, 2017, specifically regarding the furnishing of an investor presentation.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document serves as a disclosure of an investor presentation rather than a financial statement.
Material Changes
No material changes to financial performance or operations are detailed in the text of this filing. The primary event is the disclosure of an investor presentation (Exhibit 99.1) intended for use on June 1, 2017, and at subsequent meetings.
Guidance, Outlook, and Risks
Management Commentary: The company is furnishing an investor presentation dated June 2017. The information is subject to modification and will be used in meetings with investors or analysts.
Legal Status: The information in this report and its exhibits is furnished pursuant to Item 7.01 of Form 8-K. It is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section. It will not be incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (TherapeuticsMD, Inc. presentation dated June 2017) for specific financial data and strategic outlook.
- Verify the date of the investor presentation usage (June 1, 2017) against subsequent company announcements.
- Confirm that the presentation content has not been superseded by later filings or press releases.
- Note that the presentation content is not legally "filed" and may be subject to modification.